ZYCRAM 200mg Injection Vial

Frequently asked questions

• Onset of action

  The amount of time required for this medicine to show its action is not clinically established.

• Duration of Effect

  The amount of time for which this medicine remains active in the body is not clinically established.

• Safe with Alchohol?

  Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

• Is it habit forming?

  No habit forming tendency has been reported.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to ZYCRAM 200mg Injection Vial , other alkylating agents, or any other inactive ingredients present along with the formulation.

• Urinary outflow obstruction

  This medicine is not recommended for use in patients with urinary flow obstruction or cystitis (inflammation of the urinary bladder) due to the increased risk of worsening of the patient's condition.

• Bone marrow suppression

  This medicine is not recommended in patients with severe bone marrow suppression (decrease in the production of blood cells).

• Pregnancy

  This medicine is not recommended for use in pregnant women.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women.

• Secondary malignancies

  This medicine may increase the risk of secondary tumors. Most frequently, the urinary tract, thyroid gland, and blood are affected. Close monitoring of signs and symptoms is necessary. Therapy should be discontinued if malignancy develops.

• Blood cell count

  The use of this medicine is known to lower the count of white blood cells (neutrophils) and platelets. Close monitoring of complete blood cell counts is necessary before and during therapy with this medicine. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

• Cardiovascular diseases

  This medicine should be used with extreme caution in patients with a history of cardiovascular diseases due to the increased risk of worsening of the patient's condition. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary in some cases.

• Lung diseases

  This medicine should be used with caution in patients with a history of lung diseases due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary in some cases.

• Infections

  This medicine should be used with caution due to the increased risk of severe and potentially life-threatening infections. Report any unusual symptoms such as a fever, diarrhea, sore throat, pain or burning during urination, etc. to the doctor immediately. Close monitoring of the clinical condition, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary in some cases.

• Kidney impairment

  This medicine should be used with caution in patients suffering from kidney impairment due to the increased risk of severe adverse effects. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

• Liver impairment

  This medicine should be used with caution in patients suffering from liver impairment due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

• Driving or operating machinery

  This medicine may cause dizziness, drowsiness, weakness, or tiredness in some patients. Hence, it is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating heavy machinery if you experience any of these symptoms.

This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. It should be given in multiple cycles along with other chemotherapy agents. It is important to receive every scheduled dose. The blood cells count and kidney function should be assessed before starting the treatment. Any signs and symptoms of heart and lung dysfunction should be reported to the doctor on priority. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

• Usage does not depend on food timings
• To be taken as instructed by doctor
• May cause sleepiness

• medlineplus.gov - Cyclophosphamide [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a682080.html [cited 3/9/2020]. 2020